MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$1,087,060K Marketable securities$33,637K Prepaid expenses andother current assets$4,699K Total current assets$1,125,396K Operating leaseright-of-use assets$36,007K Property and equipment,net$6,718K Other assets$4,286K Restricted cash$2,855K Total assets$1,175,262K Total liabilities,convertible preferred stock...$1,175,262K Total stockholders'equity (deficit)$1,047,734K Total liabilities$127,528K Accumulated deficit-$639,283K Accumulated othercomprehensive loss-$18K Additional paid in capital$1,687,023K Total currentliabilities$62,839K Operating leaseliabilities, net of current...$32,413K Deferred revenue, net ofcurrent portion$31,148K Finance leaseliabilities, net of current...$1,128K Common stock$12K Accrued expenses andother current...$19,972K Accounts payable$18,525K Deferred revenue,current portion$10,371K Operating leaseliabilities, current portion$7,592K Term loan, net ofdiscount$5,710K Finance leaseliabilities, current portion$669K
Balance Sheet

Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines, Inc. (PBLS)

source: myfinsight.com